Daniel Waschke, PhDAssociate Regulatory Program Director at F. Hoffmann-La Roche Ltd.Speaker
Agenda Sessions
Chairman's Remarks: Regulatory CMC Strategies and Lessons Learned from Various Oligonucleotide Programs
, 13:55View Session